Healthcare • Diagnostics & Research
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if GH is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
96 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 3
600 filers reported a long position in GH for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $1.1B | 7.6M | -34% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $977.4M | 6.5M | -7.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | $863.6M | 5.8M | +2.3% |
| FMR LLC | $823.4M | 5.5M | +33.3% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $817M | 5.4M | -6.7% |
| Invesco Ltd. | $664.6M | 4.4M | -10.4% |
| GOLDMAN SACHS GROUP INC | $566.5M | 3.8M | -14.9% |
| TWO SIGMA INVESTMENTS, LP | $558M | 3.7M | -12.1% |
| Capital International Investors | $510M | 3.4M | -2.3% |
| Deep Track Capital, LP | $509.1M | 3.4M | +1.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.